Mylan and it's CEO, Heather Bresch, were under attack for a multitude of large price increases in their life saving pharmaceutical, the EpiPen. The U.S. Congress, the Federal Drug Administration (FDA), and millions of people considered at risk and in need of access to EpiPen injectors, wanted to know why and how those price increases had happened.

【書誌情報】

ページ数：15ページ

サイズ：A4

商品番号：HBSP-TB0489

発行日：2017/5/1

登録日：2017/7/6